Sales reps sue over unpaid overtime

Share this article:
Thousands of pharmaceutical sales reps have filed a series of class action lawsuit claims against their former employers seeking tens of millions of dollars in back pay.

The claims were filed in New York, California, New Jersey and Connecticut on behalf of reps from across the country seeking overtime wages dating back two to six years, under federal and state statutes of limitations.

The companies affected are Pfizer, GlaxoSmithKline, Johnson & Johnson, AstraZeneca, Amgen, Eli Lilly, Hoffmann-La Roche, Bayer and Boehringer Ingelheim.

One former Lilly rep interviewed by the Associated Press said she quit after 18 years because her job encroached on weekends and vacations.

Another plaintiff, a 20-year Pfizer veteran, said the overtime requirements were “unfair” and that her boss said she “needed to be engaged in business 24/7.”

A Pfizer spokesman said in published reports the company would contest the lawsuit.

Under federal labor law, outside sales forces can be exempt from overtime pay. The plaintiffs argue that they don't qualify as sales reps because the doctors they visit aren't actually buying anything from them, said Charles Joseph, an attorney for the workers told The New York Times.  
Drug company executives denied the arguments in published reports. The overtime cases have all been moved to federal courts.  

Share this article:

Email Newsletters

More in News

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.

Five things for pharma marketers to know: Thursday, August 21

Five things for pharma marketers to know: Thursday, ...

An Ebola survivor is set to leave Emory University Hospital, but the cause of the cure is uncertain, the FDA has approved a new type 1 diabetes test, and the ...